Type
Internal restructuring
Country
Belgium
Region
Vlaams Gewest; Prov. Antwerpen; Arr. Mechelen
Location of affected unit(s)
Sector
Professional Services
Scientific, Architectural And Engineering Technical Activities
Scientific Research And Development
72.11 - Research And Experimental Development On Biotechnology

200 jobs
Number of planned job losses
Job loss
Announcement Date
8 January 2025
Employment effect (start)
1 February 2025
Foreseen end date

Description

Galapagos, a Belgian multinational biotech company has announced restructuring measures in France, Switzerland, The Netherlands and Belgium (Mechelen). In total 300 employees will potentially face dismissal, approximately 200 of which in Belgium.

The restructuring will divide the company into different sub-entities. The new company next to Galapagos is provisionally called SpinCo. All Galapagos shareholders will receive SpinCo shares according to how many Galapagos shares they hold. Additionally, some activities will be sold off to other companies, leading to dismissals as well. As required by law, the information and consultation phase between the company management and trade unions has been initiated.


Sources

Citation

Eurofound (2025), Galapagos, Internal restructuring in Belgium, factsheet number 202168, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/202168.